Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/epfUCfbwocfGiusllUPi

April 2, 2013
Sign upForwardArchiveAdvertiseRead more at SmartBrief.com
News for nuclear medicine and molecular imaging professionals
 
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at snmmi@smartbrief.com.

  Top Story 
  • PET imaging with 18F-florbetaben IDs Alzheimer's
    Uptake of 18F-florbetaben on PET imaging scans was higher in the cerebral cortex of patients with Alzheimer's disease than in healthy study participants, according to a study published in the Journal of Nuclear Medicine. Researchers used a kinetic compartment theory of analysis for this study. "Compartment kinetic model-based quantification of [beta-amyloid] binding from 18F-florbetaben PET data is feasible, and all [beta-amyloid] binding parameters, including those by the reference tissue model and the practically useful SUVR, are excellent in discriminating between beta-amyloid–positive–and–negative scans," researchers said. MolecularImaging.net (4/1) LinkedInFacebookTwitterEmail this Story
 
  Clinical News & Research 
  • Study takes stock of thyroid cancer imaging, therapies
    Research advances in molecular imaging and therapies for thyroid cancer are transitioning into the clinical setting, according to review findings published in The Lancet. Developments in the past decade include the discovery of biomarkers that help improve personalized treatments, the study said. Kinase inhibitors and combinations of existing drugs also hold great promise for the disease. "With these unprecedented achievements, we have now entered an exciting modern era of molecular thyroid cancer medicine," researchers said. MolecularImaging.net (4/1) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Report projects radiopharmaceutical market growth
    A MarketsandMarkets report estimates the value of the worldwide radiopharmaceutical market will be $5.5 billion by 2017, up from $3.8 billion last year. The growth will be driven by factors including greater use of SPECT and PET imaging, advances in devices and increased radiopharmaceutical awareness. The report also projects growing use of technetium-99m diagnostics in markets such as Europe, North America and Japan, but it warns of isotope shortages and other challenges. AuntMinnie.com (free registration) (4/1) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Facility to handle residual material from isotope production
    The Savannah River Site's H-Canyon facility is gearing up for a number of new projects. One will involve the processing of residual material from the generation of molybdenum-99 at Atomic Energy of Canada's Chalk River facility. The material will include highly enriched uranium that originated in the U.S. Aiken Standard (S.C.) (4/1) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • Chinese health care market expected to hit $1 trillion by 2020
    The Chinese health care market is poised to reach $1 trillion by 2020, driven partly by increased spending on patient access and insurance, as well as the aging population, according to PricewaterhouseCoopers analysts. Medical device companies that are prepared to adapt to China's changing economic landscape will be in good position to capitalize on the market, they said. MassDevice.com (Boston) (4/1) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • HHS issues final regulations on Medicaid funding, expansion
    HHS issued the final rule for Medicaid expansion on Friday, under which new Medicaid beneficiaries will be guaranteed 100% funding beginning next year. The federal government will be covering all the costs of certain new Medicaid beneficiaries until 2016 before gradually going down to a permanent 90% rate by 2020. The rule will be open for comments from the public for the next 60 days. BenefitsPro.com (3/29) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  • Mobile app eases patients' fears before surgery
    A mobile health application called TouchSurgery can help lessen patients' anxiety about undergoing surgery by allowing them to view intraoperative videos or simulations of the operations they are going to have. The app, which was featured by Dr. Nancy Snyderman in an NBC News segment, is used to demystify surgical procedures and give patients confidence. Forbes (3/31) LinkedInFacebookTwitterEmail this Story
  From SNMMI 
  • Early-bird registration ends next Thursday, April 11!
    Attend this year's SNMMI Annual Meeting — June 8-12 in Vancouver, British Columbia — and take advantage of a wide range of cutting-edge scientific and CE sessions focused on the latest nuclear and molecular imaging research. Don't miss more than 100 CE sessions, 1,300+ scientific posters, nuclear medicine review course, CT case review sessions and student technologist registry review. Early-bird registration ends April 11. Register today! LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

  SmartQuote 
That which grows fast, withers as rapidly. That which grows slowly, endures."
--Josiah Gilbert Holland,
American writer and poet


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director:   Meryl Harold   (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.®  Legal Information